RxDoctor Payments Data

Jeffrey Bloom, DO

Retina Specialist · Dayton, OHNPI 1194286773

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,379 of the $8,965 with a category attached, or 71.2%. 19 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 27.9% of the total.

$8,965in general payments, 2019–2025

Across 123 payments — averaging $72.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$2K
  • Alcon$2K
  • Amgen$1K
  • AbbVie$501
  • Regeneron Healthcare Solutions, Inc.$376
  • ANI Pharmaceuticals, Inc.$350
  • plus $2K from 13 others

What the payments were for

  • Travel & lodging$2,58629%
  • Food & beverage$6,37971%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,965 in reported general payments places this provider in the 65th percentile of 69 retina specialist providers in Ohio.

See all retina specialist providers in Ohio

Medicare billing

Part B allowed, 2024
$678,520
Medicare patients
680
Services billed
7,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate340$10,809
Cyclosporine14$2,318
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat119$1,760
Ofloxacin160$1,713
Latanoprost206$1,528
Ketorolac Tromethamine67$984
Brimonidine Tartrate101$703
MoxifloxacinMoxifloxacin Hcl26$623
Timolol Maleate31$491
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha20$242
ErythromycinErythromycin Base27$179
Dorzolamide Hcl13$178
Doxycycline Hyclate14$146

Paid to pharmacies, not to this prescriber.

Other retina specialist in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →